Dr. William Shomali, MD
Claim this profileStanford Cancer Institute
Studies Fatty Liver Disease
Studies Eosinophilic Sinusitis
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials William Shomali, MD is currently running
BLU-263
for Systemic Mastocytosis
This trial tests BLU-263 combined with the best possible care for patients with specific conditions whose symptoms are not well-controlled. The medication aims to reduce symptoms by blocking overactive cells.
Recruiting0 awards Phase 2 & 312 criteria
Ruxolitinib
for Eosinophilia
This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.
Recruiting1 award Phase 219 criteria
More about William Shomali, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments William Shomali, MD has experience with
- Ruxolitinib
- BLU-263
- Placebo
Breakdown of trials William Shomali, MD has run
Fatty Liver Disease
Eosinophilic Sinusitis
Postprandial Fullness Syndrome
Hemophilia (or Haemophilia)
Splenomegaly
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Shomali, MD specialize in?
William Shomali, MD focuses on Fatty Liver Disease and Eosinophilic Sinusitis. In particular, much of their work with Fatty Liver Disease has involved JAK2 positive patients, or patients who are undergoing treatment.
Is William Shomali, MD currently recruiting for clinical trials?
Yes, William Shomali, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that William Shomali, MD has studied deeply?
Yes, William Shomali, MD has studied treatments such as Ruxolitinib, BLU-263, Placebo.
What is the best way to schedule an appointment with William Shomali, MD?
Apply for one of the trials that William Shomali, MD is conducting.
What is the office address of William Shomali, MD?
The office of William Shomali, MD is located at: Stanford Cancer Institute, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.